Feng Du
Impact in
- Reproductive Medicine top 10%
- Ovarian function and disorders
- Endometriosis Research and Treatment
- Ovarian cancer diagnosis and treatment
-
- Cancer-related molecular mechanisms research
Papers in
-
- Renal and related cancers 3
- Glycosylation and Glycoproteins Research 2
-
- Renal cell carcinoma treatment 2
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Xiao Liu (1 shared paper)Hualin Fan (1 shared paper)Xiangcai Wei (1 shared paper)Yishan Liu (1 shared paper)Hao Liu (1 shared paper)Zitao Li (1 shared paper)Zhen‐Xian Du (5 shared papers)Detian Li (4 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Frontiers in Oncology (2 papers)Sustainability (2 papers)Frontiers in Pharmacology (1 paper)Experimental Biology and Medicine (1 paper)
- Partner nations
- ChinaGermanyNew Zealand
In The Last Decade
Feng Du
19 papers receiving 324 citations
Peers
Comparison fields: 5 of 69
- Reproductive Medicine 74
- Cancer Research 37
- Immunology 54
- Nephrology 16
- Molecular Biology 105
Countries citing papers authored by Feng Du
This map shows the geographic impact of Feng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Du more than expected).
Fields of papers citing papers by Feng Du
This network shows the impact of papers produced by Feng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Du. The network helps show where Feng Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 114 | |
| 2 | 2016 | 38 | |
| 3 | 2019 | 24 | |
| 4 | 2020 | 22 | |
| 5 | 2006 | 20 | |
| 6 | 2019 | 16 | |
| 7 | 2014 | 15 | |
| 8 | 2015 | 13 | |
| 9 | 2015 | 13 | |
| 10 | Cordyceps sinensis attenuates renal fibrosis and suppresses BAG3 induction in obstructed rat kidney. | 2015 | 13 |
| 11 | 2017 | 10 | |
| 12 | 2019 | 9 | |
| 13 | 2021 | 5 | |
| 14 | BAG3 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1. | 2015 | 4 |
| 15 | 2023 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 0 |
About Feng Du
Feng Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Strategy and Management, having authored 22 papers that have together received 324 indexed citations. Recurring topics across this work include Renal and related cancers (3 papers), Glycosylation and Glycoproteins Research (2 papers), Renal cell carcinoma treatment (2 papers), Digital Platforms and Economics (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Sharing Economy and Platforms (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Reproductive Medicine (74 citations), Cancer Research (37 citations), Immunology (54 citations), Nephrology (16 citations) and Molecular Biology (105 citations). Feng Du has collaborated with scholars based in China, Germany and New Zealand. Frequent co-authors include Xiao Liu, Hualin Fan, Xiangcai Wei, Yishan Liu, Hao Liu, Zitao Li, Zhen‐Xian Du, Detian Li, Hua‐Qin Wang and Jianbin Li. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Sustainability, Frontiers in Pharmacology and Experimental Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.